NCT02477150View on ClinicalTrials.gov

Safety and Immunogenicity of a Zoster Vaccine in SLE

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 30, 2018

Study Completion Date

January 31, 2019

Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL

Zostavax

Vaccination of a zoster vaccine (Zostavax)

BIOLOGICAL

placebo

placebo administration

Trial Locations (1)

000

Department of Medicine, Tuen Mun Hospital, Hong Kong

All Listed Sponsors
lead

Tuen Mun Hospital

OTHER_GOV

NCT02477150 - Safety and Immunogenicity of a Zoster Vaccine in SLE | Biotech Hunter | Biotech Hunter